摘要
Click chemistry, introduced by Sharpless and colleagues in 2001, has fundamentally transformed the way chemists and biologists construct molecules, probe biological systems, and develop therapeutics. Defined by its hallmark attributes—high yields, exquisite selectivity, mild reaction conditions, and compatibility with aqueous environments—click chemistry has evolved from an elegant synthetic concept into an indispensable technological platform. This comprehensive review systematically examines the mechanistic underpinnings and synthetic scope of the principal click reactions: copper(I) catalyzed azide alkyne cycloaddition (CuAAC), strain promoted azide alkyne cycloaddition (SPAAC), inverse electron demand Diels Alder (IEDDA) reactions involving tetrazines and strained alkenes, Staudinger ligation, oxime and hydrazone conjugation, and thiol ene additions. We critically evaluate their applications across the drug discovery pipeline—from fragment based screening and combinatorial library synthesis to activity based protein profiling (ABPP) and covalent drug design—and across the increasingly strategic arena of bioconjugation, encompassing antibody drug conjugates (ADCs), site specific protein modification, PEGylation, and radiolabelled imaging agents. Special attention is devoted to bioorthogonal click chemistry, which has enabled real time molecular imaging in living organisms and tissue selective prodrug activation. Emerging frontiers including sulfur(VI) fluoride exchange (SuFEx), photoclick chemistry, and click to release strategies are thoroughly discussed. We also address persistent challenges—copper cytotoxicity, pharmacokinetic liabilities of triazole containing drugs, and linker stability in ADCs—and outline translational pathways toward clinical implementation. Collectively, this review underscores click chemistry's transformative role in bridging synthetic chemistry and molecular medicine, and charts a future where precision bioconjugation enables next generation targeted therapies.